RIBAVIRIN Side Effects

7021568-5 | Dizziness, Hair Disorder, Hyperhidrosis, Infection, Pruritus, Rash, Urine Output Decreased
on Sep 15, 2010 Male patient from UNITED STATES , 33 years of age, was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hair disorder, hyperhidrosis, infection (What is infection?), pruritus, rash (What is rash?), urine output decreased. Ribavirin dosage: .

7021567-3 | Dysuria, Fatigue, Headache, Injection Site Reaction, Pain, Urine Colour Abnormal, Urine Odour Abnormal, Vertigo
Patient was taking Ribavirin (View Usage). Patient had the following side effects: dysuria, fatigue, headache (What is headache?), injection site reaction, pain (What is pain?), urine colour abnormal, urine odour abnormal, vertigo on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, . Ribavirin dosage: .

7019526-X | Dizziness, Dyspnoea, Haemoglobin Decreased, Palpitations, Sinus Tachycardia, Syncope, Ventricular Extrasystoles
Adverse event was reported on Sep 14, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: 1200 Mg, Daily, 1000 Mg, Daily) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: EGYPT , 55 years of age, weighting 218.3 lb, After Ribavirin was administered, patient had the following side effects: dizziness (What is dizziness?), dyspnoea, haemoglobin decreased, palpitations, sinus tachycardia, syncope, ventricular extrasystoles. During the same period patient was treated with PEG INTRON (150 ?g 1x/week Subcutaneous; 120 ?g 1x/week Subcutaneous) (View Peg-intron Review and Peg-intron Label ), PEG INTRON (150 ?g 1x/week Subcutaneous; 120 ?g 1x/week Subcutaneous) (View Peg-intron Review and Peg-intron Label ).

7018028-4 | Macular Oedema, Scotoma, Visual Acuity Reduced
on Sep 14, 2010 Male patient from UNITED KINGDOM , 48 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: macular oedema, scotoma, visual acuity reduced. Ribavirin dosage: (600 Mg Bid Oral). During the same period patient was treated with PEGASYS ((18 ?g, Subcutaneous)) (View Pegasys Review and Pegasys Label ).


7015590-2 | Bone Marrow Failure, Cardiac Failure Congestive, Dyspnoea, Glomerulonephritis Membranoproliferative, Hepatitis Virus-associated Nephropathy, Nephrotic Syndrome, Renal Failure Acute
on Sep 15, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: bone marrow failure, cardiac failure congestive, dyspnoea, glomerulonephritis membranoproliferative, hepatitis virus-associated nephropathy, nephrotic syndrome, renal failure acute. Ribavirin dosage: Po. During the same period patient was treated with PEG INTERFERON (INTERFERON) (View Peg Interferon (interferon) Review and Peg Interferon (interferon) Label ). Patient was hospitalized.

7015471-4 | Diabetes Mellitus, Disease Recurrence, Hepatic Cirrhosis, Hepatitis C, Liver Transplant, Nephritic Syndrome, Renal Impairment
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: diabetes mellitus, disease recurrence, hepatic cirrhosis, hepatitis c (What is hepatitis c?), liver transplant (What is liver transplant?), nephritic syndrome, renal impairment on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ), INSULIN (View Insulin Review and Insulin Label ).

7015454-4 | Dyslipidaemia, Glomerulonephritis Membranous, Hypoalbuminaemia, Nephrotic Syndrome, Oedema Peripheral
Adverse event was reported on Sep 15, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: dyslipidaemia, glomerulonephritis membranous, hypoalbuminaemia, nephrotic syndrome, oedema peripheral. During the same period patient was treated with PEGINTERFERON (INTERFERON) (View Peginterferon (interferon) Review and Peginterferon (interferon) Label ). Patient was hospitalized.

7009886-8 | Anaemia, Leukopenia, Weight Decreased
on Sep 16, 2010 Male patient from GERMANY , weighting 198.4 lb, was treated with Ribavirin (View Usage). Patient had the following side effects: anaemia, leukopenia, weight decreased. Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

7009198-2 | Hypoaesthesia, Optic Atrophy, Pancytopenia, Papilloedema, Paraesthesia
on Sep 06, 2010 Male patient from UNITED STATES , 52 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: hypoaesthesia, optic atrophy, pancytopenia, papilloedema, paraesthesia. Ribavirin dosage: 1000mg, Daily. During the same period patient was treated with PEGINTERFERON ALFA 2A (180 ?g, Q Week) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ELETRIPTAN HYDROBROMIDE (View Eletriptan Hydrobromide Review and Eletriptan Hydrobromide Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), SALMETEROL (View Salmeterol Review and Salmeterol Label ), BUPROPION (View Bupropion Review and Bupropion Label ).

7009138-6 | Abnormal Behaviour, Homicidal Ideation
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, homicidal ideation on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , child 4 years of age, . Ribavirin dosage: Trpl.

7007217-0 | Diabetic Ketoacidosis, Type 1 Diabetes Mellitus
Adverse event was reported on Sep 08, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 55 years of age, Patient had the following side effects: diabetic ketoacidosis, type 1 diabetes mellitus.

6978576-X | Adrenal Insufficiency, Tooth Abscess
on Sep 07, 2010 Female patient from FRANCE , weighting 127.9 lb, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: adrenal insufficiency, tooth abscess. Ribavirin dosage: Route, Dose Form: As Per Protocol.. During the same period patient was treated with EPOETIN BETA (Dose:30,000 ^ui^,form:30,000 ^ui^,date Of Last Dose Prior To Sae: 14 May 2009) (View Epoetin Beta Review and Epoetin Beta Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6970181-4 | Dry Mouth, Loss Of Consciousness, Memory Impairment, Pneumonia, Productive Cough
on Aug 27, 2010 Male patient from UNITED STATES , 48 years of age, was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, loss of consciousness, memory impairment, pneumonia (What is pneumonia?), productive cough. Ribavirin dosage: .

6969450-3 | Decreased Appetite, Inappropriate Antidiuretic Hormone Secretion, Insomnia, Malaise
Patient was taking Ribavirin (View Usage). Patient had the following side effects: decreased appetite, inappropriate antidiuretic hormone secretion, insomnia, malaise on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: Po. During the same period patient was treated with PEG INTERFERON (INTERFERONS) (Sc) (View Peg Interferon (interferons) Review and Peg Interferon (interferons) Label ). Patient was hospitalized.

6968573-2 | Syncope
Adverse event was reported on Aug 31, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: ) . Location: HUNGARY , weighting 136.7 lb, After Ribavirin was administered, patient had the following side effects: syncope. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ). Patient was hospitalized.

6959474-4 | Anaemia, Bile Duct Stone, Hyperthyroidism, Osteoporosis
on Aug 20, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, bile duct stone, hyperthyroidism, osteoporosis (What is osteoporosis?). Ribavirin dosage: Po. During the same period patient was treated with INFERGEN (View Infergen Review and Infergen Label ). Patient was hospitalized.

6958465-7 | Coagulopathy, Renal Tubular Necrosis
on Aug 18, 2010 Male patient from IRAN (ISLAMIC REPUBLIC OF) , 30 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: coagulopathy, renal tubular necrosis. Ribavirin dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ).

6945956-8 | Decreased Appetite, Inappropriate Antidiuretic Hormone Secretion, Insomnia
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: decreased appetite, inappropriate antidiuretic hormone secretion, insomnia on Aug 18, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: Po. During the same period patient was treated with PEG INTERFERON (INTERFERON) (Sc) (View Peg Interferon (interferon) Review and Peg Interferon (interferon) Label ). Patient was hospitalized.

6937432-3 | Blood Test Abnormal, Ovarian Cyst, Uterine Disorder
Adverse event was reported on Aug 16, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 7.72 lb, Patient experienced the following unwanted or unexpected effects: blood test abnormal, ovarian cyst (What is ovarian cyst?), uterine disorder. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), METFORMIN (View Metformin Review and Metformin Label ), GLYBURIDE (From Week 22-28) (View Glyburide Review and Glyburide Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ).

6936608-9 | Chest Pain, Dyspepsia, Dysphagia, Insomnia, Oropharyngeal Pain, Tooth Extraction
on Aug 05, 2010 Male patient from UNITED STATES , 29 years of age, was treated with Ribavirin (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspepsia, dysphagia, insomnia, oropharyngeal pain, tooth extraction. Ribavirin dosage: .

6936430-3 | Dry Mouth, Loss Of Consciousness, Memory Impairment, Pneumonia, Productive Cough
on Aug 05, 2010 Male patient from UNITED STATES , 48 years of age, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: dry mouth, loss of consciousness, memory impairment, pneumonia (What is pneumonia?), productive cough. Ribavirin dosage: .

6932502-8 | Anaemia, Autoimmune Disorder, Dehydration, Diarrhoea, Weight Decreased
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, autoimmune disorder, dehydration, diarrhoea, weight decreased on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with hepatitis c virus test positive and. Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6932294-2 | Autoimmune Thyroiditis, Diabetic Ketoacidosis
Adverse event was reported on Aug 16, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: ) . Location: KOREA, REPUBLIC OF , 33 years of age, Patient had the following side effects: autoimmune thyroiditis, diabetic ketoacidosis. During the same period patient was treated with PEG INTERFERON ALPHA 2B (View Peg-interferon Alpha 2b Review and Peg-interferon Alpha 2b Label ).

6930345-2 | Acute Myocardial Infarction, Anaemia, Haemoptysis, Pulmonary Renal Syndrome
on Aug 09, 2010 Male patient from SINGAPORE , 52 years of age, was diagnosed with hepatitis c (What is hepatitis c?), anaemia, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: acute myocardial infarction, anaemia, haemoptysis, pulmonary renal syndrome. Ribavirin dosage: . During the same period patient was treated with EPOGEN (View Epogen Review and Epogen Label ), PEG INTRON (View Peg-intron Review and Peg-intron Label ), SULPHASALAZINE (View Sulphasalazine Review and Sulphasalazine Label ), METHYLPREDNISOLONE (For 3 Days.) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6927466-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Rash Erythematous, Rash Papular, Rash Pruritic
on Aug 02, 2010 Female patient from UNITED STATES , 47 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, platelet count decreased, rash erythematous, rash papular, rash pruritic. Ribavirin dosage: 1200mg, Daily. During the same period patient was treated with PEGYLATED INTERFERON ALFA 2A (180ug Weekly) (View Pegylated Interferon Alfa-2a Review and Pegylated Interferon Alfa-2a Label ).

6927457-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blister, Injection Site Rash, Platelet Count Decreased, Rash Papular, Rash Pruritic, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Patient was taking Ribavirin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blister, injection site rash, platelet count decreased, rash papular, rash pruritic, red blood cell count decreased, white blood cell count decreased on Aug 02, 2010 from UNITED STATES Additional patient health information: Female patient , 43 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: 1200mg, Daily. During the same period patient was treated with PEGYLATED INTERFERON ALFA 2A (180ug Weekly) (View Pegylated Interferon Alfa-2a Review and Pegylated Interferon Alfa-2a Label ).

6927455-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blister, Discomfort, Platelet Count Decreased, Rash Papular, Rash Pruritic, White Blood Cell Count Decreased
Adverse event was reported on Aug 02, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: 120mg, Daily) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 51 years of age, After Ribavirin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blister, discomfort, platelet count decreased, rash papular, rash pruritic, white blood cell count decreased. During the same period patient was treated with PEGYLATED INTERFERON ALFA 2A (180ug Weekly) (View Pegylated Interferon Alfa-2a Review and Pegylated Interferon Alfa-2a Label ).

6920193-1 | Liver Transplant Rejection
on Aug 04, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with hepatitis c virus test positive and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: liver transplant rejection. Ribavirin dosage: Po. During the same period patient was treated with PEG INTERFERON (INTERFERONS) (Sc) (View Peg Interferon (interferons) Review and Peg Interferon (interferons) Label ), PROGRAF (View Prograf Review and Prograf Label ).

6919147-0 | Condition Aggravated
on Aug 03, 2010 Female patient from CHINA , 71 years of age, weighting 163.1 lb, was diagnosed with supportive care and was treated with Ribavirin (View Usage). Patient had the following side effects: condition aggravated. Ribavirin dosage: . During the same period patient was treated with OSELTAMIVIR (View Oseltamivir Review and Oseltamivir Label ), CEFOPERAZONE/SULBACTAM (View Cefoperazone/sulbactam Review and Cefoperazone/sulbactam Label ), ETIMICIN SULFATE (View Etimicin Sulfate Review and Etimicin Sulfate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DOXOFYLLINE (View Doxofylline Review and Doxofylline Label ).

6895744-6 | No Adverse Event
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: no adverse event on Jun 29, 2010 from UNITED STATES Additional patient health information: Female patient , 25 years of age, . Ribavirin dosage: .

6874761-6 | Device Related Sepsis, Loss Of Consciousness
Adverse event was reported on Jul 16, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 45 years of age, Patient experienced the following unwanted or unexpected effects: device related sepsis, loss of consciousness. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6857953-1 | Retinal Haemorrhage, Visual Acuity Reduced
on Jun 28, 2010 Female patient from KOREA, REPUBLIC OF , 54 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: retinal haemorrhage, visual acuity reduced. Ribavirin dosage: Df. During the same period patient was treated with PEG INTRON (Df) (View Peg-intron Review and Peg-intron Label ).

6857944-0 | Abdominal Pain, Asthenia, Change Of Bowel Habit, Condition Aggravated, Herpes Simplex, Lethargy, Malaise
on Jun 30, 2010 Male patient from UNITED KINGDOM , 46 years of age, weighting 194.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, change of bowel habit, condition aggravated, herpes simplex (What is herpes simplex?), lethargy, malaise. Ribavirin dosage: ; Po. During the same period patient was treated with INTERFERON (; Sc) (View Interferon Review and Interferon Label ).

6844306-5 | Cholecystitis
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis on Jul 08, 2010 from IRELAND Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with hepatitis c (What is hepatitis c?), arthralgia, biliary colic and. Ribavirin dosage: 3 Doses Twice A Day. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), ACETAMINOPHEN (A As Per Needed) (View Acetaminophen Review and Acetaminophen Label ), ENDONE (Frequency: 1 As Necessary) (View Endone Review and Endone Label ). Patient was hospitalized.

6841967-1 | Blister, Hepatitis C Rna Increased, Injection Site Erythema, Injection Site Pruritus, Injection Site Swelling, Pyrexia, Skin Erosion, Transaminases Increased
Adverse event was reported on Jun 28, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: Df) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 73 years of age, Patient had the following side effects: blister, hepatitis c rna increased, injection site erythema, injection site pruritus, injection site swelling, pyrexia, skin erosion, transaminases increased. During the same period patient was treated with PEGINTERFERON ALFA 2B (Df) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ). Patient was hospitalized.

6841908-7 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Cytolytic Hepatitis, Hepatic Encephalopathy, Hepatomegaly, Iron Overload, Peritonitis Bacterial
on Jun 28, 2010 Female patient from FRANCE , 63 years of age, was diagnosed with hepatitis c (What is hepatitis c?), cytolytic hepatitis, anaemia prophylaxis and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, cytolytic hepatitis, hepatic encephalopathy, hepatomegaly, iron overload, peritonitis bacterial. Ribavirin dosage: Df. During the same period patient was treated with REBETOL (1 G Qd) (View Rebetol Review and Rebetol Label ), FERROUS SULFATE TAB (80 Mg Qd) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), PEGINTERFERON ALFA 2B (Df) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ), PEGINTERFERON ALFA 2B (Df) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), INTRON A (View Intron A Review and Intron A Label ), BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ).

6840823-2 | Abortion Spontaneous, Pregnancy Of Partner
on Jun 28, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy of partner. Ribavirin dosage: Df. During the same period patient was treated with PEGASYS (Df) (View Pegasys Review and Pegasys Label ).

6839217-5 | Diarrhoea Haemorrhagic, Pouchitis
Patient was taking Ribavirin (View Usage). Patient had the following side effects: diarrhoea haemorrhagic, pouchitis on Jun 28, 2010 from JAPAN Additional patient health information: Female patient , 41 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: (600 Mg, Daily). During the same period patient was treated with PEG INTRON ((1.5 ?g/kg 1x/week)) (View Peg-intron Review and Peg-intron Label ).

6838531-7 | Abdominal Pain, Asthenia, Change Of Bowel Habit, Condition Aggravated, Herpes Simplex, Lethargy, Malaise
Adverse event was reported on Jun 30, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: ;po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED KINGDOM , 46 years of age, weighting 194.0 lb, After Ribavirin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, change of bowel habit, condition aggravated, herpes simplex (What is herpes simplex?), lethargy, malaise. During the same period patient was treated with INTERFERON (;sc) (View Interferon Review and Interferon Label ).

6838528-7 | Lumbar Spinal Stenosis, Monoplegia, Purulence, Pyrexia, Spondylitis, Staphylococcus Test Positive
on Jun 30, 2010 Female patient from JAPAN , 55 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: lumbar spinal stenosis, monoplegia, purulence, pyrexia, spondylitis, staphylococcus test positive. Ribavirin dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ). Patient was hospitalized.

6836073-6 | Anaemia, Syncope
on Mar 09, 2010 Male patient from CANADA , weighting 151.0 lb, was treated with Ribavirin (View Usage). Patient had the following side effects: anaemia, syncope. Ribavirin dosage: Frequency: Daily, Last Dose Prior To Sae: 15 August 2008. During the same period patient was treated with PEGINTERFERON ALFA 2A (Dose Form Reported As Syringe, Last Dose Prior To Sae:08 August 2008) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), CORTISONE CREAM (Frequency: Prn) (View Cortisone Cream Review and Cortisone Cream Label ), IBUPROFEN (Frequency: Prn) (View Ibuprofen Review and Ibuprofen Label ), ZOPICLONE (Frequency: Prn) (View Zopiclone Review and Zopiclone Label ), ALLER AID (Frequency: Prn) (View Aller-aid Review and Aller-aid Label ).

6831783-9 | Bone Marrow Failure, Cardiac Failure Congestive, Disease Recurrence, Nephrotic Syndrome, Renal Failure Acute
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: bone marrow failure, cardiac failure congestive, disease recurrence, nephrotic syndrome, renal failure acute on Jun 25, 2010 from JAPAN Additional patient health information: Female patient , 73 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: Po. During the same period patient was treated with PEG INTERFERON (INTERFERONS) (View Peg Interferon (interferons) Review and Peg Interferon (interferons) Label ). Patient was hospitalized.

6831781-5 | Blood Pressure Increased, Cerebral Infarction
Adverse event was reported on Jun 23, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: 600 Mg;qd;po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, cerebral infarction. During the same period patient was treated with PEGINTERFERON ALFA 2A (180 Mcg;qw;sc) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ).

6829830-3 | Pregnancy Test False Positive
on Jun 28, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Ribavirin (View Usage). Patient had the following side effects: pregnancy test false positive. Ribavirin dosage: .

6822479-8 | Pregnancy Test False Positive
on Jun 28, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: pregnancy test false positive. Ribavirin dosage: .

6822071-5 | Alanine Aminotransferase Increased, Alopecia Universalis, Aspartate Aminotransferase Increased, Dermatitis, Eczema, Hypothyroidism, Irritability, Neutropenia, Palpitations
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, alopecia universalis, aspartate aminotransferase increased, dermatitis, eczema (What is eczema?), hypothyroidism, irritability, neutropenia, palpitations on Jun 17, 2010 from ITALY Additional patient health information: Female patient , 40 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: (1000 Mg, Daily). During the same period patient was treated with PEGINTERFERON ALFA 2A (See Image) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), PEGINTERFERON ALFA 2A (See Image) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), PEGINTERFERON ALFA 2A (See Image) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), PEGINTERFERON ALFA 2A (See Image) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ).

6821191-9 | Alopecia Universalis, Depression, Neutropenia, Serum Ferritin Decreased
Adverse event was reported on Jun 17, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: (800 Mg, Daily)) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: ITALY , 36 years of age, Patient had the following side effects: alopecia universalis, depression (What is depression?), neutropenia, serum ferritin decreased. During the same period patient was treated with PEGINTERFERON ALFA 2B ((80 ?g 1x/week Subcutaneous), (50 ?g 1x/week Subcutaneous)) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ), PEGINTERFERON ALFA 2B ((80 ?g 1x/week Subcutaneous), (50 ?g 1x/week Subcutaneous)) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).

6819908-2 | Cardiomyopathy
on Jun 28, 2010 Male patient from UNITED STATES , 49 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6819898-2 | Cardiomyopathy
on Jun 28, 2010 Male patient from UNITED STATES , 64 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?). Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6818763-4 | Amnesia, Asthenia, Chills, Fall, Headache, Lethargy, Syncope
Patient was taking Ribavirin (View Usage). Patient had the following side effects: amnesia, asthenia, chills, fall (What is fall?), headache (What is headache?), lethargy, syncope on Jun 22, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 141.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: 1000 Mg;qd;po. During the same period patient was treated with PEGASYS (0.5 Ml;qw;sc) (View Pegasys Review and Pegasys Label ).